DPP4 and COVID-19: Although in silico experiments that predict the compatible binding between DPP4 and S glycoprotein of SARS-CoV-2 have not been demonstrated to date in vitro or in vivo, the impact of DPP4 on the COVID-19 physiopathology goes further, due to the multiple functions developed by the protease.